Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present at the Canaccord Genuity Growth Conference on Wednesday, August 9, 2017 at 3:30 p.m. Eastern Time in Boston, MA. Dr. Anido will provide